Takeda Certified as a Great Place to Work Globally, Including Australia

Takeda Certified as a Great Place to Work® Globally, Including Australia

January 16, 2026

Takeda has been Certified™ as a Great Place to Work® in 25 countries, including Australia, based on confidential feedback from employees through the Great Place to Work® Trust Index™ survey.

This recognition builds on a proud tradition: for the past nine consecutive years, Takeda Australia has been certified as a Top Employer. These certifications reflect what employees experience every day—a workplace where colleagues are trusted to deliver, supported to grow, and treated with respect. They stand as a testament to the organisation’s values, which guide decisions and behaviours in the moments that matter, and to its commitment to fostering an environment where every voice is heard and every colleague can thrive.

Takeda’s purpose continues to guide how its people work and lead. The organisation remains committed to creating an environment where individuals can do their best work—whether partnering with healthcare professionals, enabling clinical and commercial excellence, supporting operations, or ensuring reliable access to medicines. Takeda recognises that when employees feel safe to speak up, included in decision‑making, and supported by their leaders, teams work better together and patient outcomes remain the priority.

Jenn Jones, Head of HR and DE&I Chair Oceania said:

“This recognition is especially meaningful because it’s driven by the voices of our people. It’s the everyday gestures; a genuine ‘how can I help?’, a teammate cheering your achievements, or the confidence to speak up and know you’ll be heard that truly define our culture. These moments of trust and support are what set Takeda apart, and we’re proud to keep listening, learning, and acting on what matters most to our colleagues.”

Dave Pearce, General Manager, Oceania, added:

“I want to recognise the contribution our teams make every day. I am extremely proud of what we are achieving in Australia and how that delivers value to patients. This is grounded in our values and in how we support each other, so people can do their best work and keep growing.”

Great Place to Work® Certification™ is based on employee feedback and assesses workplace experience in areas including trust in leadership, respect, fairness, pride and camaraderie.

Takeda is committed to creating an environment where its people can thrive. The organisation delivers on this promise in several ways:
Flexibility that works for all: offering adaptable ways of working and benefits that support every stage of life.
Wellbeing that matters: recognised as an Advanced Workplace by Mental Health First Aid Australia, Takeda provides a wide range of resources to support employees and their families, promoting health and wellbeing.
Growth that inspires: delivering learning and development opportunities that build skills and accelerate careers.
Belonging that empowers: fostering an inclusive culture where diverse perspectives are celebrated and every voice counts.

To learn more about careers at Takeda Australia and explore current opportunities, visit https://jobs.takeda.com/search-jobs/australia/

About Takeda

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com.

Media Contact:

Takeda Oceania Communications

[email protected]

Important Notice

For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.

The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.

Takeda has been Certified™ as a Great Place to Work® in 25 countries, including Australia, based on confidential feedback from employees through the Great Place to Work® Trust Index™ survey. This recognition builds on a proud tradition: for the past nine consecutive years, Takeda Australia has been certified as a Top Employer. These certifications reflect what employees experience every day—a workplace where colleagues are trusted to deliver, supported to grow, and treated with respect. They stand as a testament to the organisation’s values, which guide decisions and behaviours in the moments that matter, and to its commitment to fostering an environment where every voice is heard and every colleague can thrive. Takeda’s purpose continues to guide how its people work and lead. The organisation remains committed to creating an environment where individuals can do their best work—whether partnering with healthcare professionals, enabling clinical and commercial excellence, supporting operations, or ensuring reliable access to medicines. Takeda recognises that when employees feel safe to speak up, included in decision‑making, and supported by their leaders, teams work better together and patient outcomes remain the priority. Jenn Jones, Head of HR and DE&I Chair Oceania said: *“This recognition is especially meaningful because it’s driven by the voices of our people. It’s the everyday gestures; a genuine ‘how can I help?’, a teammate cheering your achievements, or the confidence to speak up and know you’ll be heard that truly define our culture. These moments of trust and support are what set Takeda apart, and we’re proud to keep listening, learning, and acting on what matters most to our colleagues.”* Dave Pearce, General Manager, Oceania, added: *“I want to recognise the contribution our teams make every day. I am extremely proud of what we are achieving in Australia and how that delivers value to patients. This is grounded in our values and in how we support each other, so people can do their best work and keep growing.”* Great Place to Work® Certification™ is based on employee feedback and assesses workplace experience in areas including trust in leadership, respect, fairness, pride and camaraderie. * Takeda is committed to creating an environment where its people can thrive. The organisation delivers on this promise in several ways: * Flexibility that works for all: offering adaptable ways of working and benefits that support every stage of life. * Wellbeing that matters: recognised as an *Advanced Workplace* by Mental Health First Aid Australia, Takeda provides a wide range of resources to support employees and their families, promoting health and wellbeing. * Growth that inspires: delivering learning and development opportunities that build skills and accelerate careers. * Belonging that empowers: fostering an inclusive culture where diverse perspectives are celebrated and every voice counts. To learn more about careers at Takeda Australia and explore current opportunities, visit [https://jobs.takeda.com/search-jobs/australia/]( https://jobs.takeda.com/search-jobs/australia/) ## About Takeda Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit [www.takeda.com](https://www.takeda.com/). ### Media Contact: Takeda Oceania Communications [[email protected]](mailto:[email protected]) ## Important Notice For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws. The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.